Soden
David Paul Soden, Mission Viejo, CA US
Patent application number | Description | Published |
---|---|---|
20130201641 | PORTABLE CHARGING CABLE WITH IN-LINE CONTROLLER - A portable electric vehicle support equipment (EVSE) unit is formed as a cord of plural insulated conductors and a flexible outer sheath enclosing said plural insulated conductors. The cord includes an EVSE docking connector on a docking end of the cord and a utility plug on a utility end of the cord, said cord being divided into a docking section terminated at said docking connector and a utility section terminated at said utility connector. The cord further includes an in-line EVSE controller and a housing enclosing said controller, said housing sealed with said flexible outer sheath and disposed at an intermediate section of said cord between said docking and utility sections. | 08-08-2013 |
20140035527 | ELECTRIC VEHICLE DOCKING CONNECTOR WITH EMBEDDED EVSE CONTROLLER - A portable electric vehicle supply equipment (EVSE) kit or system includes a docking connector having a docking head engagable with the charging port of an electric vehicle and a barrel or handle fixed to the docking head and having a barrel electrical connector. An EVSE controller is embedded within the docking connector. An electric power cable has a first connector for engaging the barrel electrical connector and a second connector at an opposite end of the cable for connection to an electrical utility receptacle. The embedded EVSE controller enables the docking connector to function as an EVSE unit. | 02-06-2014 |
Declan Soden, Cork IE
Patent application number | Description | Published |
---|---|---|
20150307897 | NON-VIRAL VECTOR - The present invention provides a non-viral vector which comprises a sequence encoding an RNA replicase and a nuclear localisation sequence. The vector may also comprise a nucleotide sequence of interest (NOI). The vector may be used to deliver an NOI to a target cell. | 10-29-2015 |
Declan Soden, County Cork IE
Patent application number | Description | Published |
---|---|---|
20120172784 | DEVICE FOR TREATING TISSUE - An apparatus for use in carrying out a prophylactic or treatment procedure on tissue comprises a head piece | 07-05-2012 |
Douglas G. Soden, San Pedro, CA US
Patent application number | Description | Published |
---|---|---|
20090044896 | HIGH TEMPERATURE CERAMIC-BASED THERMAL PROTECTION MATERIAL - A thermal protection paste as described herein can be used by itself, or impregnated into a high temperature resistant fabric to form a repair patch, to repair a thermal protection structure. The paste includes a ceramic composition that includes ceramic material having at least a first controlled particle size and a second controlled particle size that is larger than the first controlled particle size. The ceramic composition is mixed into a high temperature ceramic precursor resin to form the paste. The paste (or patch) is applied to the structure under repair and initially heated to cure the paste and to secure it in place. When the paste and/or patch is cured, it becomes a cross-linked polymer having high thermal protection characteristics. When the paste is exposed to very high temperature, e.g., spacecraft reentry temperatures, it pyrolizes and retains its high thermal protection characteristics. | 02-19-2009 |
20090263664 | COMPOSITION AND METHOD FOR CORROSION PROTECTION OF A STRUCTURE - A method and composition for corrosion protection of a structure is provided. In one disclosed embodiment, a polysiloxane ureide which inhibits corrosion formation on a surface of a physical object is provided. The polysiloxane ureide has a backbone including, (i) at least one diamine-terminated polysiloxane as disclosed; (ii) at least one aromatic diamine; and, (iii) at least one diisocyanate. In another disclosed embodiment, there is provided a polyureide which inhibits corrosion formation on a surface of a physical object. The polyureide comprises: (i) at least one aliphatic diamine; (ii) at least one aromatic diamine; and, (iii) at least one diisocyanate. | 10-22-2009 |
20110143145 | Composition and Method for Corrosion Protection of a Structure - A method and composition for corrosion protection of a structure is provided. In one disclosed embodiment, a polysiloxane ureide which inhibits corrosion formation on a surface of a physical object is provided. The polysiloxane ureide has a backbone including, (i) at least one diamine-terminated polysiloxane as disclosed; (ii) at least one aromatic diamine; and, (iii) at least one diisocyanate. In another disclosed embodiment, there is provided a polyureide which inhibits corrosion formation on a surface of a physical object. The polyureide comprises: (i) at least one aliphatic diamine; (ii) at least one aromatic diamine; and, (iii) at least one diisocyanate. | 06-16-2011 |
Jeffrey J. Soden, Midlothian, VA US
Patent application number | Description | Published |
---|---|---|
20130072407 | PREPARATION AND USE OF AMINOALKYLPHOSPHONIC ACID DILAKYL ESTER COMPOUNDS IN A LUBRICANT FOR ANTIWEAR, FRICTION REDUCTION, AND/OR MICROPITTING PREVENTION - In accordance with the disclosure, one aspect of the present application is directed to a lubricant additive composition. The lubricant additive composition includes a component or mixture of components selected from (a) an aminoalkylphosphonic acid dialkyl ester; (b) a cyclized product of an aminoalkylphosphonic acid dialkyl ester; and a mixture of (a) and (b). Preparation and use of the additive composition in a lubricant for antiwear and/or friction reduction are also disclosed. | 03-21-2013 |
Peter Ernest Soden, Hertfordshire GB
Patent application number | Description | Published |
---|---|---|
20110014182 | ANTIGEN BINDING PROTEINS - Antigen binding proteins that bind β-amyloid peptide, in particular human β-amyloid peptide; methods of treating diseases or disorders characterised by elevated β-amyloid levels or β-amyloid deposits, particularly Alzheimer's disease and diseases or disorders affecting the eye or optic nerve characterised by elevated β-amyloid levels or β-amyloid deposits, including age related macular degeneration and glaucoma type diseases and β-amyloid dependent cataract formation, with said antigen binding proteins; pharmaceutical compositions comprising said antigen binding proteins; and methods of manufacture. | 01-20-2011 |
20110064740 | ANTIGEN BINDING PROTEINS - The present invention relates to methods of treating diseases or disorders affecting the eye or optic nerve characterised by elevated β-amyloid levels or β-amyloid deposits, particularly age related macular degeneration and glaucoma type diseases and β-amyloid dependent cataract formation, with antigen binding proteins that bind β-amyloid peptide and in particular human β-amyloid peptide. | 03-17-2011 |
Peter Ernest Soden, Stevenage GB
Patent application number | Description | Published |
---|---|---|
20090162358 | ANTIGEN BINDING PROTEINS - Antigen binding proteins that bind β-amyloid peptide, in particular human β-amyloid peptide; methods of treating diseases or disorders characterised by elevated β-amyloid levels or β-amyloid deposits, particularly Alzheimer's disease and diseases or disorders affecting the eye or optic nerve characterised by elevated β-amyloid levels or β-amyloid deposits, including age related macular degeneration and glaucoma type diseases and β-amyloid dependent cataract formation, with said antigen binding proteins; pharmaceutical compositions comprising said antigen binding proteins; and methods of manufacture. | 06-25-2009 |
Peter Ernest Soden, Essex GB
Patent application number | Description | Published |
---|---|---|
20110142824 | Antibodies Against Amyloid-Beta Peptide - Antibodies that bind human β-amyloid peptide, methods of treating diseases or disorders characterised by elevated β-amyloid levels or β-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture. | 06-16-2011 |
Peter Ernest Soden, Harlow GB
Patent application number | Description | Published |
---|---|---|
20140050719 | ANTIBODIES - Antibodies that bind human β-amyloid peptide, methods of treating diseases or disorders characterised by elevated β-amyloid levels or β-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture. | 02-20-2014 |
Sarah Soden, Kansas City, MO US
Patent application number | Description | Published |
---|---|---|
20150310163 | SYSTEM FOR GENOME ANALYSIS AND GENETIC DISEASE DIAGNOSIS - The method for genome analysis translates the clinical findings in the patient into a comprehensive test order for genes that can be causative of the patient's illness, delimits analysis of variants identified in the patient's genome to those that are “on target” for the patient's illness, and provides clinical annotation of the likely causative variants for inclusion in a variant warehouse that is updated as a result of each sample that is analyzed and that, in turn, provides a source of additional annotation for variants. The method uses a genome sequence having the steps of entering at least one clinical feature of a patient by an end-user, assigning a weighted value to the term based on the probability of the presence of the term, mapping the term to at least one disease by accessing a knowledge base containing a plurality of data sets, wherein the data sets are made up of associations between (i) clinical features and diseases, (ii) diseases and genes, (iii) genes and genetic variants, and (iv) diseases and gene variants, assigning a truth value to each of the mapped terms based on the associated data sets and the weighted value, to provide a list of results of possible diagnoses prioritized based on the truth values, with continuous adjustment of the weightings of associations in the knowledge base based on updating of each discovered diagnosis and attendant clinical features, genes and gene variants. This method can be performed in fifty hours or twenty-four hours or less. | 10-29-2015 |